Charles River Labs Files Q1 2025 10-Q
Ticker: CRL · Form: 10-Q · Filed: May 7, 2025 · CIK: 1100682
| Field | Detail |
|---|---|
| Company | Charles River Laboratories International, INC. (CRL) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
CRL Q1 2025 10-Q is in. Financials for Service & Product segments detailed.
AI Summary
Charles River Laboratories International, Inc. filed its 10-Q for the period ending March 29, 2025. The filing details financial performance across its Service and Product segments for the first quarter of 2025, comparing it to the same period in 2024. Key financial data related to common stock, paid-in capital, retained earnings, and treasury stock as of December 28, 2024, are also presented.
Why It Matters
This filing provides investors with the latest financial snapshot of Charles River Laboratories, crucial for understanding the company's performance and making informed investment decisions.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.
Key Numbers
- 2025-03-29 — Reporting Period End (End of the first quarter of fiscal year 2025.)
- 2024-12-28 — Prior Year End (Balance sheet figures as of the end of the previous fiscal year.)
Key Players & Entities
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (company) — Filer
- 20250329 (date) — Reporting Period End Date
- 20250507 (date) — Filing Date
- 251 BALLARDVALE ST (address) — Business and Mail Address
- WILMINGTON, MA (location) — City, State of Business Address
FAQ
What were the key financial highlights for Charles River Laboratories in Q1 2025 compared to Q1 2024?
The filing provides segment data for 'Service' and 'Product' for the periods ending March 29, 2025, and March 30, 2024, allowing for comparison, though specific revenue or profit figures are not detailed in this header information.
What is the company's primary business classification?
Charles River Laboratories International, Inc. is classified under 'SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]'.
When is Charles River Laboratories' fiscal year end?
The company's fiscal year ends on December 27.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 7, 2025.
What are the main components of the company's equity as of December 28, 2024?
The filing indicates components such as Common Stock, Additional Paid-In Capital, Retained Earnings, Accumulated Other Comprehensive Income, and Treasury Stock.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).